10-Q Filing

BLUE BIOFUELS, INC. CIK: 1549145 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001145443-13-001660`
Period End Date	20130630
Filing Date	20130812
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	amgh-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 24 Cash Flow Statement 42

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$18.05K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Preferred Stock, Shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$4.00	USD	Point-in-time
Preferred Stock, Shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrentAndNoncurrent`	$30.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrentAndNoncurrent`	$30.00K	USD	Point-in-time
Preferred Stock, Shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred Stock, Shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common Stock, Par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
TOTAL CURRENT ASSETS AND TOTAL ASSETS	`Assets`	$30.00K	USD	Point-in-time
TOTAL CURRENT ASSETS AND TOTAL ASSETS	`Assets`	$48.05K	USD	Point-in-time
Common Stock, Par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, Shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, Shares issued	`CommonStockSharesIssued`	19.39M	shares	Point-in-time
Common Stock, Shares issued	`CommonStockSharesIssued`	19.39M	shares	Point-in-time
Common Stock, Shares outstanding	`CommonStockSharesOutstanding`	19.39M	shares	Point-in-time
Accrued interest	`AccruedLiabilitiesCurrent`	$3.70K	USD	Point-in-time
Accrued interest	`AccruedLiabilitiesCurrent`	$7.88K	USD	Point-in-time
Common Stock, Shares outstanding	`CommonStockSharesOutstanding`	19.39M	shares	Point-in-time
Accrued expenses	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.47K	USD	Point-in-time
Shareholder loans	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Shareholder loans	`DueToRelatedPartiesCurrent`	$18.48K	USD	Point-in-time
Notes	`ConvertibleDebtCurrent`	$80.00K	USD	Point-in-time
Notes	`ConvertibleDebtCurrent`	$110.00K	USD	Point-in-time
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	`Liabilities`	$85.17K	USD	Point-in-time
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	`Liabilities`	$136.36K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 100,000,000 shares authorized; 19,395,000 shares issued and outstanding at December 31, 2012 and June 30, 2013, respectively	`CommonStockValue`	$19.39K	USD	Point-in-time
Common stock, $.001 par value; 100,000,000 shares authorized; 19,395,000 shares issued and outstanding at December 31, 2012 and June 30, 2013, respectively	`CommonStockValue`	$19.39K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.45K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.45K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$148.15K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$105.01K	USD	Point-in-time
Stock Subscription Receivable	`CommonStockShareSubscribedButUnissuedSubscriptionsReceivable`	$19.00K	USD	Point-in-time
Stock Subscription Receivable	`CommonStockShareSubscribedButUnissuedSubscriptionsReceivable`	$9.00K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIENCY	`StockholdersEquity`	$-55.16K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIENCY	`StockholdersEquity`	$-88.31K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	`LiabilitiesAndStockholdersEquity`	$30.00K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	`LiabilitiesAndStockholdersEquity`	$48.05K	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	2 Qtrs
Revenues	`Revenues`	-	USD	5 Qtrs
Revenues	`Revenues`	-	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$39.23K	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$21.59K	USD	1 Quarter
Operating Expenses	`OperatingExpenses`	$38.96K	USD	2 Qtrs
Operating Expenses	`OperatingExpenses`	$140.28K	USD	5 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$2.21K	USD	1 Quarter
Interest expense	`InterestExpense`	$7.88K	USD	5 Qtrs
Interest expense	`InterestExpense`	$4.18K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-43.14K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-39.23K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-148.15K	USD	5 Qtrs
Net Loss	`NetIncomeLoss`	$-23.80K	USD	1 Quarter
Basic earnings (loss) per share-Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Basic earnings (loss) per share-Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic earnings (loss) per share-Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic earnings (loss) per share-Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	5 Qtrs
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.39M	shares	2 Qtrs
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	18.70M	shares	1 Quarter
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	-	shares	5 Qtrs
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.39M	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net (loss)	`NetIncomeLoss`	$-43.14K	USD	2 Qtrs
Net (loss)	`NetIncomeLoss`	$-39.23K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-148.15K	USD	5 Qtrs
Net (loss)	`NetIncomeLoss`	$-23.80K	USD	1 Quarter
Change in accounts payable	`IncreaseDecreaseInAccountsPayable`	-	USD	5 Qtrs
Change in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.47K	USD	2 Qtrs
Increase in prepaid expense	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Increase in prepaid expense	`IncreaseDecreaseInPrepaidExpense`	$30.00K	USD	5 Qtrs
Increase in Accrued interest	`IncreaseDecreaseInAccruedInterestReceivableNet`	$-7.88K	USD	5 Qtrs
Increase in Accrued interest	`IncreaseDecreaseInAccruedInterestReceivableNet`	$-4.18K	USD	2 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-40.44K	USD	2 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-170.28K	USD	5 Qtrs
Sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00K	USD	2 Qtrs
Sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$49.95K	USD	5 Qtrs
Proceeds from notes payable	`ProceedsFromConvertibleDebt`	$30.00K	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromConvertibleDebt`	$110.00K	USD	5 Qtrs
Proceeds from shareholder advances	`ProceedsFromRelatedPartyDebt`	$18.46K	USD	5 Qtrs
Proceeds from shareholder advances	`ProceedsFromRelatedPartyDebt`	$18.48K	USD	2 Qtrs
Additional paid-in capital	`ProceedsFromAdditionalPaidInCapital`	$9.89K	USD	5 Qtrs
Additional paid-in capital	`ProceedsFromAdditionalPaidInCapital`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$188.33K	USD	5 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$58.48K	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.05K	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.05K	USD	5 Qtrs
Cash and cash equivalents at beginning of period	`Cash`	$18.05K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`Cash`	$4.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`Cash`	$18.05K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`Cash`	-	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`Cash`	$4.00	USD	Point-in-time
Income Taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxesPaidNet`	-	USD	5 Qtrs
Interest Expense	`InterestPaid`	-	USD	5 Qtrs
Interest Expense	`InterestPaid`	-	USD	2 Qtrs
Total	`CashPaidDuringPeriod`	-	USD	2 Qtrs
Total	`CashPaidDuringPeriod`	-	USD	5 Qtrs
Sale of Common Stock	`SaleOfCommonStock`	$29.95K	USD	5 Qtrs
Sale of Common Stock	`SaleOfCommonStock`	-	USD	2 Qtrs
Stock Subscription Receivable	`StocksSubscriptionReceivable`	-	USD	2 Qtrs
Stock Subscription Receivable	`StocksSubscriptionReceivable`	$19.00K	USD	5 Qtrs
Total	`NoncashInvestingAndFinancing`	-	USD	2 Qtrs
Total	`NoncashInvestingAndFinancing`	$48.95K	USD	5 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.